Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Current Ratio Over TimeElevated
Percentile Rank83
3Y CAGR+46.1%
5Y CAGR+7.8%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
+46.1%/yr
vs -13.2%/yr prior
5Y CAGR
+7.8%/yr
Recent acceleration
Acceleration
+59.3pp
Accelerating
Percentile
P83
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 13.25 | +17.8% |
| 2024 | 11.26 | +5.4% |
| 2023 | 10.68 | +151.4% |
| 2022 | 4.25 | -13.5% |
| 2021 | 4.91 | -46.1% |
| 2020 | 9.11 | +124.5% |
| 2019 | 4.06 | -45.8% |
| 2018 | 7.49 | -23.3% |
| 2017 | 9.77 | -41.7% |
| 2016 | 16.75 | - |